Harbour Investments, Inc. Bria Cell Therapeutics Corp. Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$7.1 - $10.61 $781 - $1,167	-110 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.4 - $9.28 $330 - $696	-75 Reduced 40.54%	110 $1,000
Q2 2021 Aug 16, 2021	BUY	$2.89 - $6.57 $57 - $131	20 Added 12.12%	185 $1,000
Q1 2021 Aug 17, 2021	BUY	$3.15 - $6.17 $504 - $987	160 Added 3200.0%	165 $1,000
Q1 2021 May 12, 2021	BUY	$3.15 - $6.17 $15 - $30	5 New	5 $0

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $11.8M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.